Benchmark Capital Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | $533K | Sell |
34,544
-7,000
| -17% | -$108K | 0.53% | 53 |
|
|
2018
Q3 | $895K | Sell |
41,544
-2,700
| -6% | -$58.2K | 0.67% | 49 |
|
|
2018
Q2 | $1.08M | Sell |
44,244
-800
| -2% | -$19.5K | 0.81% | 42 |
|
|
2018
Q1 | $770K | Sell |
45,044
-2,500
| -5% | -$42.7K | 0.61% | 52 |
|
|
2017
Q4 | $901K | Buy |
47,544
+17,700
| +59% | +$335K | 0.7% | 44 |
|
|
2017
Q3 | $525K | Sell |
29,844
-2,100
| -7% | -$36.9K | 0.41% | 67 |
|
|
2017
Q2 | $1.06M | Sell |
31,944
-300
| -0.9% | -$9.96K | 0.84% | 42 |
|
|
2017
Q1 | $1.04M | Buy |
32,244
+1,600
| +5% | +$51.4K | 0.82% | 39 |
|
|
2016
Q4 | $1.11M | Buy |
30,644
+15,175
| +98% | +$550K | 0.92% | 34 |
|
|
2016
Q3 | $712K | Hold |
15,469
| – | – | 0.54% | 53 |
|
|
2016
Q2 | $777K | Buy |
15,469
+1,494
| +11% | +$75K | 0.63% | 49 |
|
|
2016
Q1 | $748K | Buy |
+13,975
| New | +$748K | 0.66% | 48 |
|